Riders · The University of Texas at Austin · Article III: Agencies of Education
Pharmacy Funding
Rider 14 in the 2026-27 Act, page III-115
Through the session
- 2024-25 Act Not in this version
- Introduced (Senate) Not in this version
- Introduced (House) Not in this version
- Senate substitute Not in this version
- House substitute Not in this version
- House passed Not in this version
- Conference New rider 14
- 2026-27 Act Unchanged rider 14
Pick any two steps to compare their wording.
Possible match, under review
This rider resembles the following, but not closely enough to say they are the same without reading both.
- Texas Digital Molten Salt Reactor (2024-25 Act, rider 10, The University of Texas at Austin)
What changed in the text
Conference → 2026-27 Act: the same text in both versions.
Removed words are struck through; added words are underlined. Sources: Conference · 2026-27 Act.
Every version: numbers, statuses and source pages
| Version | Rider | Against the version before | Against the current budget | Source |
|---|---|---|---|---|
| 2024-25 ActGeneral Appropriations Act, 2024-25 Biennium | Not in this version | |||
| Introduced (Senate)Senate Bill 1 as introduced (LBB recommended, Senate) | Not in this version | |||
| Introduced (House)House Bill 1 as introduced (LBB recommended, House) | Not in this version | |||
| Senate substituteCommittee Substitute for Senate Bill 1 | Not in this version | |||
| House substituteHouse Committee Substitute for Senate Bill 1 | Not in this version | |||
| House passedSenate Bill 1 as passed the second house | Not in this version | |||
| ConferenceConference Committee Report for Senate Bill 1 | 14 | New | Possible match, under review | Page III-92 |
| 2026-27 ActGeneral Appropriations Act, 2026-27 Biennium | 14 | Unchanged | Possible match, under review | Page III-115 |
Full text of each wording
Conference, 2026-27 Act
Source, page III-115Pharmacy Funding. Out of funds appropriated above in Strategy C.1.2, Pharmacy Funding, $2,500,000 from the General Revenue Fund in fiscal year 2026 and $2,500,000 from the General Revenue Fund in fiscal year 2027 shall be used for supporting the pharmacy program. Any unexpended balances as of August 31, 2026, are appropriated for the same purpose for the fiscal year beginning September 1, 2026.